Order Article Reprints

Bissa M, Galli V, Schifanella L, Vaccari M, Rahman MA, Gorini G, Binello N, Sarkis S, Gutowska A, Silva de Castro I, et al. In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4⁺ T-Cells. Vaccines. 2023; 11(11):1662. https://doi.org/10.3390/vaccines11111662

Bissa, Massimiliano, Veronica Galli, Luca Schifanella, Monica Vaccari, Mohammad Arif Rahman, Giacomo Gorini, Nicolò Binello, Sarkis Sarkis, Anna Gutowska, Isabela Silva de Castro, and et al. 2023. "In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4⁺ T-Cells" Vaccines 11, no. 11: 1662. https://doi.org/10.3390/vaccines11111662

Bissa, M., Galli, V., Schifanella, L., Vaccari, M., Rahman, M. A., Gorini, G., Binello, N., Sarkis, S., Gutowska, A., Silva de Castro, I., Doster, M. N., Moles, R., Ferrari, G., Shen, X., Tomaras, G. D., Montefiori, D. C., N’guessan, K. F., Paquin-Proulx, D., Kozlowski, P. A., ... Franchini, G. (2023). In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4⁺ T-Cells. Vaccines, 11(11), 1662. https://doi.org/10.3390/vaccines11111662